Literature DB >> 28212698

Is it Time for Immunotherapy Trials in Narcolepsy?

Andreas Lutterotti1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28212698      PMCID： PMC5337581          DOI： 10.5664/jcsm.6478

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  15 in total

1.  Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.

Authors:  Michel Lecendreux; Stephanie Maret; Claudio Bassetti; Marie-Christine Mouren; Mehdi Tafti
Journal:  J Sleep Res       Date:  2003-12       Impact factor: 3.981

2.  Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.

Authors:  Stine Knudsen; Bo Biering-Sørensen; Birgitte R Kornum; Eva R Petersen; Jette D Ibsen; Steen Gammeltoft; Emmanuel Mignot; Poul J Jennum
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

3.  Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis.

Authors:  Wynne Chen; Jed Black; Pamela Call; Emmanuel Mignot
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

4.  Follow-up of four narcolepsy patients treated with intravenous immunoglobulins.

Authors:  Yves Dauvilliers
Journal:  Ann Neurol       Date:  2006-07       Impact factor: 10.422

5.  Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.

Authors:  Minae Kawashima; Ling Lin; Susumu Tanaka; Poul Jennum; Stine Knudsen; Sona Nevsimalova; Giuseppe Plazzi; Emmanuel Mignot
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

6.  Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Authors:  Syed Sohail Ahmed; Wayne Volkmuth; José Duca; Lorenzo Corti; Michele Pallaoro; Alfredo Pezzicoli; Anette Karle; Fabio Rigat; Rino Rappuoli; Vas Narasimhan; Ilkka Julkunen; Arja Vuorela; Outi Vaarala; Hanna Nohynek; Franco Laghi Pasini; Emanuele Montomoli; Claudia Trombetta; Christopher M Adams; Jonathan Rothbard; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

7.  Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.

Authors:  Yves Dauvilliers; Bertrand Carlander; François Rivier; Jacques Touchon; Mehdi Tafti
Journal:  Ann Neurol       Date:  2004-12       Impact factor: 10.422

8.  Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.

Authors:  Vesna Cvetkovic-Lopes; Laurence Bayer; Stéphane Dorsaz; Stéphanie Maret; Sylvain Pradervand; Yves Dauvilliers; Michel Lecendreux; Gert-Jan Lammers; Claire E H M Donjacour; Renaud A Du Pasquier; Corinne Pfister; Brice Petit; Hyun Hor; Michel Mühlethaler; Mehdi Tafti
Journal:  J Clin Invest       Date:  2010-02-15       Impact factor: 14.808

Review 9.  Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.

Authors:  S Sohail Ahmed; Peter H Schur; Noni E MacDonald; Lawrence Steinman
Journal:  J Autoimmun       Date:  2014-02-19       Impact factor: 7.094

10.  Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy.

Authors:  Yves Dauvilliers; Jan Bauer; Valérie Rigau; Nicole Lalloyer; Pierre Labauge; Bertrand Carlander; Roland Liblau; Christelle Peyron; Hans Lassmann
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.